$353.81
1.08% yesterday
NYSE, Nov 06, 10:00 pm CET
ISIN
US8636671013
Symbol
SYK

Stryker Stock price

$353.81
-12.47 3.40% 1M
-23.71 6.28% 6M
-6.24 1.73% YTD
-15.21 4.12% 1Y
+140.29 65.70% 3Y
+140.37 65.77% 5Y
+256.21 262.51% 10Y
+309.95 706.67% 20Y
NYSE, Closing price Thu, Nov 06 2025
-3.86 1.08%

New AI Insights on Stryker Insights AI Insights on Stryker

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$135.3b
Enterprise Value
$146.8b
Net debt
$11.5b
Cash
$3.3b
Shares outstanding
382.3m
Valuation (TTM | estimate)
P/E
46.5 | 26.1
P/S
5.5 | 5.3
EV/Sales
6.0 | 5.8
EV/FCF
36.0
P/B
6.2
Dividends
DPS
$3.24
Yield 1Y | 5Y
0.9% | 1.1%
Growth 1Y | 5Y
6.2% | 8.7%
Payout 1Y | 3Y
41.8% | 41.1%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$24.4b | $25.3b
EBITDA
$6.1b | $7.2b
EBIT
$5.4b | $6.5b
Net Income
$2.9b | $5.2b
Free Cash Flow
$4.1b
Growth (TTM | estimate)
Revenue
11.0% | 11.9%
EBITDA
11.7% | 27.2%
EBIT
11.5% | 28.4%
Net Income
-18.0% | 73.1%
Free Cash Flow
27.1%
Margin (TTM | estimate)
Gross
64.6%
EBITDA
25.0% | 28.5%
EBIT
22.1%
Net
12.1% | 20.5%
Free Cash Flow
16.7%
Financial Health
Equity Ratio
48.0%
Return on Equity
14.5%
ROCE
13.6%
ROIC
-
Debt/Equity
0.7
More
EPS
$7.6
FCF per Share
$10.7
Short interest
1.0%
Employees
53k
Rev per Employee
$430.0k
Show more

Is Stryker a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Stryker Stock Analysis

Unlock Scores for Free

Analyst Opinions

37 Analysts have issued a Stryker forecast:

26x Buy
70%
11x Hold
30%

Analyst Opinions

37 Analysts have issued a Stryker forecast:

Buy
70%
Hold
30%

Financial data from Stryker

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
24,381 24,381
11% 11%
100%
- Direct Costs 8,633 8,633
9% 9%
35%
15,748 15,748
12% 12%
65%
- Selling and Administrative Expenses 8,121 8,121
13% 13%
33%
- Research and Development Expense 1,529 1,529
9% 9%
6%
6,098 6,098
12% 12%
25%
- Depreciation and Amortization 699 699
13% 13%
3%
EBIT (Operating Income) EBIT 5,399 5,399
12% 12%
22%
Net Profit 2,943 2,943
18% 18%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Stryker directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Stryker Stock News

Positive
Seeking Alpha
2 days ago
Stryker (SYK) delivered strong Q3 2025 results, raising full-year guidance on robust organic growth across both MedSurg & Neurotechnology and Orthopaedics segments. SYK achieved double-digit organic sales and EPS growth, supported by margin expansion and successful product launches. Despite operational strength, SYK trades at a significant valuation premium to sector peers, with a PEG ratio abo...
Positive
Seeking Alpha
4 days ago
Stryker continues to deliver strong organic growth, having posted organic growth rates of around 10% for a long period of time now. The $4.9 billion Inari Medical acquisition announced this year will boost the neurovascular business and slightly increase leverage, but deleveraging attempts are quite impressive. Valuation multiples have compressed to 26x earnings, making SYK more appealing as ea...
Neutral
Seeking Alpha
8 days ago
Stryker Corporation ( SYK ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Kevin Lobo - Chairman, CEO & President Jason Beach - Vice President of Finance & Investor Relations Preston Wells - VP & CFO Conference Call Participants Robert Marcus - JPMorgan Chase & Co, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Ryan Zimmerman - BTIG, ...
More Stryker News

Company Profile

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

Head office United States
CEO Kevin Lobo
Employees 53,000
Founded 1941
Website www.stryker.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today